Editorial Rehospitalization after Living Kidney Donation

Readmission for acute conditions has become an important metric for health systems in looking at the success of their original treatment for a particular con-dition. Indeed, it is so important that there are specific financial penalties relating to readmissions for specific conditions. In general, readmission analysis has focused on the short term (30 days) and on complications that arise in conjunction with the original cause for admission. In this issue of CJASN, Schold et al. (1) examine all-cause readmissions for a living-donor population at 1 and 3 after living donation. Segev et al. (2) assessed a large cohort of living kidney donors and determined that they hadno significant differences in surgicalmortality and long-term survival compared with a survey as